Australian Biotechnology News

clinical trials

  • Positive results for Specialised Therapeutics Australia in lung cancer trial 18/03/2010 11:46:00

    Phase III trial shows breast cancer drug, Abraxane, effective against lung cancer.
    Phase III trial shows breast cancer drug, Abraxane, effective against lung cancer.
  • Bionomics announces positive results in phase Ia trial of anti-stress drug 02/03/2010 18:20:00

    Final results of phase Ia trial of BNC210 announced demonstrating safety and efficacy.
    Final results of phase Ia trial of BNC210 announced demonstrating safety and efficacy.
  • HalcyGen sees success in SUBA-Itraconazole study 02/03/2010 18:10:00

    Preliminary results look good in clinical pharmacokinetic study comparing SUBA-Itraconazole with Sporanox.
    Preliminary results look good in clinical pharmacokinetic study comparing SUBA-Itraconazole with Sporanox.
  • Prima BioMed new COO to drive CVac to market 25/01/2010 11:31:00

    Matthew Lehman new chief operating officer for Prima BioMed will help commercialise CVac.
    Matthew Lehman new chief operating officer for Prima BioMed will help commercialise CVac.
  • QRxPharma kicks off pivotal trial for MoxDuo 02/12/2009 16:24:00

    Phase III trial for MoxDuo IR in the U.S. with final trial to begin in 2010.
    Phase III trial for MoxDuo IR in the U.S. with final trial to begin in 2010.
  • Tell the Government how to attract clinical trials 30/11/2009 15:40:00

    Submissions now open for Federal Government's Clinical Trials Action Group.
    Submissions now open for Federal Government's Clinical Trials Action Group.
  • FDA committee gives Pharmaxis tick of approval 23/11/2009 12:20:00

    Lung function test recommended for approval for us in the U.S. by FDA Pulmonary-Allergy Drugs Advisory Committee.
    Lung function test recommended for approval for us in the U.S. by FDA Pulmonary-Allergy Drugs Advisory Committee.
  • Biotech Market Spotlight: QRxPharma and Living Cell Technology 16/11/2009 13:15:00

    QRxPharma raises $21.6 m and Living Cell Technology offers share purchase plan.
    QRxPharma raises $21.6 m and Living Cell Technology offers share purchase plan.
  • Patrys moves forward with ARC grant 11/11/2009 11:03:00

    University of Melbourne researchers collaborating with Patrys receive $300K grant for anti-cancer treatment.
    University of Melbourne researchers collaborating with Patrys receive $300K grant for anti-cancer treatment.
  • Priority status granted to ChemGenex's leukaemia treatment 10/11/2009 17:06:00

    FDA grants ChemGenex Priority Review for New Drug Application for Omapro.
    FDA grants ChemGenex Priority Review for New Drug Application for Omapro.
  • Opinion: Xenotransplantation: medical advance denied 09/11/2009 17:01:00

    With New Zealand government recently opening the door to xenotransplantation trials – it is time for the Australian government to reconsider its moratorium.
    With New Zealand government recently opening the door to xenotransplantation trials – it is time for the Australian government to reconsider its moratorium.
  • Victoria simplifies clinical trial approval process 28/10/2009 15:17:00

    Ethical reviews for multi-site trials will only require a single approval.
    Ethical reviews for multi-site trials will only require a single approval.
  • Special feature: Top 10 clinical trial mistakes 14/10/2009 10:51:00

    Here are 10 common clinical trial mistakes you should avoid.
    Here are 10 common clinical trial mistakes you should avoid.
  • Feature: Closing the gap 08/10/2009 16:41:00

    A groundbreaking clinical trial is underway in the Northern Territory that could help prevent an all-too-common disease and change the way vaccinations are delivered to children.
    A groundbreaking clinical trial is underway in the Northern Territory that could help prevent an all-too-common disease and change the way vaccinations are delivered to children.
  • Trial failures a setback to stem cell therapies 21/09/2009 16:08:00

    Two recent failed clinical trials have dealt a blow to stem cell research.
    Two recent failed clinical trials have dealt a blow to stem cell research.
More >
Syndicate content
 
Jobs
Sponsored Links